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Antibacterial activityAbstract Novel compounds with antibacterial properties: pyrazoline derivatives were synthesized
by the cyclization of various -1-[2-(alkoxy)phenyl]-3-(furan-2-yl) prop-2-en-1-one 1a–1d with N-
substituted phenyl hydrazine in the presence of CH3COOH in ethanol. The structures of these com-
pounds were elucidated by, IR, 1H NMR, 13C NMR, ESI-MS spectral data and their purities were
conﬁrmed by elemental analyses. The in vitro antibacterial activity of these compounds was evaluat-
ed against two Gram-positive and two Gram-negative bacteria Aeromonas hydrophila, Yersinia
enterocolitica, Listeria monocytogenes, and Staphylococcus aureus by microdilution method and
then the minimum inhibitory concentration (MIC) of compounds were determined. The results
showed that compounds (5R)-5-(furan-2-yl)-1-phenyl-3-[2-(benzyloxy)phenyl]-4, 5-dihydro-1H-
pyrazole (2b) and (5R)-5-(furan-2-yl)-1-phenyl-3-[2-(naphthalen-2-ylmethoxy prop-2-en-1-y-
loxy)phenyl]-4,5-dihydro-1H-pyrazole (2d) showing most promising antibacterial activities as com-
pared to Gentamicin and Tetracycline are given.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Bacterial infections such as food poisoning, salmonellosis
and diarrhea are caused by multidrug-resistant Gram-positiveand Gram-negative Aeromonas hydrophila, Yersinia entero-
colitica, Listeria monocytogenes and Staphylococcus aureus
pathogens (Vivekanandhan et al., 2002). One million people
in the subtropical regions of the world are infected and
20,000 deaths every year due to these parasitic bacterial
infections. The spread of drug resistance Aeromonas is of
concern because recent surveys indicate the emergence of the-
se organisms as primary human pathogens and pose a public
health risk and an etiological agent of gastroenteritis in epi-
demics. It is speculated that resistance to multiple antibiotics
in Aeromonas isolate may be mediated by several conducible
enzymes under the selection pressure of certain widely
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due to the production of multiple inducible, chromosomally
encoded b-lactames (Gonˇi-Urriza et al., 2000a,b) Multiple
antibiotic resistances among Aeromonas sp. have been report-
ed from many parts of the world (WHO, 2006; Gonˇi-Urriza
et al., 2000b). Amoxicillin, norﬂoxacin, ciproﬂoxacin are the
principal drugs of choice in the treatment of bacterial infec-
tion since they are effective against extraintestinal and intesti-
nal wall infections (Datta et al., 1974), but these are
associated with several side effects such as nausea, metallic
taste, dizziness, hypertension, etc. as well as resistance that
have been reported (Alauddin and Smith, 1962). The devel-
opment of nitrogen-containing ﬁve-membered heterocycles,
pyrazolines is well known, representing a class of compounds
of great importance of pyrazoline derivatives that possess
biological activities like, antidepressant (Prasad et al.,
2005), anticonvulsant (Amnerkar and Bhusari, 2010) antimi-
crobial (Ozdemir et al., 2007), analgesic (Aysel Gursoy et al.,
2000), and antitumor (Brzozwskim et al., 2000), activities and
also serve as human acyl-CoA: cholesterol acyltransferase
inhibitors (Jeong et al., 2004). After the pioneering works
of Fischer and Kno¨venagel in the late 19th century, 8 the
reaction of a,b-unsaturated aldehydes and ketones with
hydrazines became one of the most popular methods for
the preparation of 2-pyrazolines (Sammour, 1964;
Bhatnagar and George, 1968; Aubagnac et al., 1969;
Andotra et al., 1993; Bilgin et al., 1994 and Mishriky
et al., 1996). As a result, numerous substituted 2-pyrazolines
have been synthesized, which has made possible structure–ac-
tivity relationship investigations of these substances. In view
of the therapeutic importance of these pyrazole heterocycles,
the goal is to investigate the synthesis of pyrazoline. The pre-
sent work is an extension of our ongoing efforts toward the
development and identiﬁcation of new pyrazole molecules to
act as antibacterial agents. Here in we describe the synthesis
of new pyrazoline derivative from various chalcones and
screened for antibacterial Activity.2. Experimental
2.1. Instrumentation
The entire chemicals were purchased from Aldrich Chemical
Company (USA) and were used without further puriﬁcation.
The reactions were monitored by percolated aluminium Silica
Gel 60F 254 thin layer plates procured from Merck
(Germany). All melting points that were measured with a
capillary apparatus are uncorrected. All the compounds were
routinely checked by IR, 1H NMR, 13C NMR, mass spec-
trometry and elemental analyses. IR spectra were recorded
in KBr on a Perkin–Elmer model 1620 FTIR spectropho-
tometer. 1H NMR and 13C NMR spectra were recorded at
ambient temperature using a Brucker spectrospin DPX-
400 MHz spectrophotometer in CDCl3 and DMSO. The fol-
lowing abbreviations were used to indicate the peak multi-
plicity s–singlet, d–doublet, t–triplet, m–multiplet. S1-MS
mass spectra were recorded on a JEOL SX102 mass spec-
trometer using Argon/Xenon (6 kV, 10 mB) gas. Column
chromatography was performed on silica gel (Merck).
Anhydrous sodium sulfate was used as a drying agent for
the organic phase.2.2. General procedure for the synthesis of (2E)-l-(2-
hydroxyphenyl)-3-(furan-2-yl) prop-2-en-1-one (1)
A solution of O-hydroxy acetophenone (1 equiv) and fur-
furaldehyde (1 equiv) in methanolic solution of NaOH (30%)
was stirred for 8 h at room temperature. After completion of
reaction, the solution was poured into ice cold water of pH-2
(pH adjusted by HCl). The solid was separated and dissolved
in CHCl3, washed with saturated solution of NaHCO3 and
evaporated to dryness. The residue was puriﬁed by column
chromatography using CHCl3 as eluent. The compound was
recrystallized in ethanol (Husain et al., 2008).
Yellow needle; yield: 95%; m.p. 84 C. Anal. Calc. for
C13H10O3: C, 72.89; H, 4.67. Found: C, 72.85; H, 4.64%. IR
(KBr) mmax (cm
1): 1634 (C‚O), 2949 (O–H); 1H NMR
(400 MHz, CDCl3): d/ppm: 12.7 (1H, s, –OH), 8.02 (1H,d,
Jtrans = 15.4 Hz, H-3), 7.72(1H, d, Jtrans = 15.4 Hz, H-2),
7.34 (1H, d{dd}, Jp,m,o = 1.6 Hz, 3.5 Hz, 8.1 Hz, Ar-H), 7.25
(1H,m, Ar-H), 7.13 (1H, m, Ar-H), 7.02 (1H, dd, J= 1.5 Hz,
3.4 Hz, Ar-H), 7.31 (1H, t, J= 3.2 Hz, Ar-H), 6.92 (1H, m,
Ar-H), 6.74 (1H, t, J= 8.3 Hz, Ar-H); 13C NMR (400 MHz,
CDCl3): d/ppm: 192.4 (C‚O), 142.6 (C‚C), 137.8 (C‚C),
152.8, 150.7, 148.6, 138.2, 136.2, 129.4, 128.7, 127.3, 125.5,
123.4, (Ar-C); GC–MS m/z (rel. int.%): 215, calc. 214.
2.3. General procedure for the synthesis (2E)-1-[2-(prop-2-en-
1-yloxy)phenyl]-3-(furan-2-yl) prop-2-en-1-one (1a)
A suspension of l-(2-hydroxyphenyl)-3-(furan-2-yl) prop-2-en-
1-one (1) (2.0 g, 0.005 mol), allyl bromide (1.5 ml, 0.0041 mol),
freshly ignited K2CO3 (1.0 g) and tetrabutylammonium iodide
as PTC (1.0 g) in dry acetone (25 ml) was heated at reﬂux for
1 h with stirring. In the absence of PTC, reaction occurred in
70–80 h and yields of the alkoxy chalcones. Use of PTC in the-
se reactions, not only decreased the reaction time up to 4–5 h
but also improved the yield of 1-[2-(prop-2-en-1-y-
loxy)phenyl]-3-(thiophen-2-yl) prop-2-en-1-one derivatives up
to 80–85%. The products thus obtained were puriﬁed by pass-
ing through silica-gel column (60–120 mesh) and further crys-
tallized from methanol to afford 1a (Kumar and Yusuf, 2006).
Light brown; yield: 85%; m.p. 82 C. Anal. Calc. for
C16H14O3: C, 75.59; H, 5.51. Found: C, 75.56; H, 5.48%. IR
(KBr) mmax (cm
1): 1655 (C‚O), 1598 (CH‚CH); 1H NMR
(400 MHz, CDCl3): d/ppm: 7.61 (1H, d, Jtrans = 15.2 Hz, H-
3), 7.52 (1H, d, Jtrans = 15.3 Hz, H-2), 7.45 (1H, m, d{dd},
Jp,m,o = 0.7 Hz, 1.8 Hz, 7.5 Hz, Ar-H), 7.01(2H, t, Ar-H),
6.82 (1H, d, Ar-H), 6.51 (IH, m, Ar-H),6.43 (1H, m, Ar-H),
6.02 (1H,m,Ar-H), 5.45 (2H, q, J = 6.7 Hz, –CH2), 5.24 (1H,
dd, Jvic = 6.2 Hz, –CH), 4.64 (2H, dd, Jvic = 5.1 Hz, –CH2);
13C NMR (400 MHz, CDCl3): d/ppm: 192.2 (C‚O), 154.5,
153.6, 144.6 (C‚C), 141.5 (C‚C), 132.5, 131.4, 130.8 128.8,
126.7, 125.8, 120.8 122.6 (Ar-C), 68.5 (CH2), 62.4 (CH2),
42.3 (CH); MS; m/z (M+) 255.
2.3.1. (2E)-1-[2-(Benzyloxy)phenyl]-3-(furan-2-yl)prop-2-en-
1-one (1b)
A suspension of 1 (2.0 g, 0.001 mol), benzyl chloride (1.5 g,
0.004 mol), under the similar conditions was used for 1a and
further crystallized from methanol to afford 1b.
Dark brown; yield: 85%; m.p. 85 C. Anal. Calc. for
C20H16O3: C, 78.94; H, 5.26. Found: C, 78.90; H, 5.23%. IR
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1): 1603 (C‚O), 1552 (CH‚CH); 1H NMR
(400 MHz, CDCl3): d/ppm: 7.62 (1H, d, Jtrans = 15.7 Hz, H-
3), 7.54 (1H, d{dd}, Jp,m,o = 0.9 Hz, 1.4 Hz, 7.8 Hz, Ar-H),
7.44 (4H, m, Ar-H), 7.43 (1H, d, Jtrans = 15.6 Hz, H-2), 7.31
(3H, m, Ar-H), 7.05 (1H, m, Ar-H), 7.03 (2H, m, Ar-H),
6.72 (1H, d, Jo = 7.9 Hz, Ar-H), 5.18 (2H, s, –CH2);
13C
NMR (400 MHz, CDCl3): d/ppm: 191.4(C‚O), 154.1, 153.5,
143.8 (C‚C), 141.3, 132.6, 130.9, 130.0, 129.6, 129.6, 128.1,
127.5, 125.8, 122.7, 122.5, 120.4, 121.2, 121.2, 112.7(Ar-C),
77.42 (CH2); MS; m/z (M
+) 305.
2.3.2. (2E)-1-[2-(Ethaloxy)phenyl]-3-(furan-2-yl)prop-2-en-
1-one (1c)
A suspension of (1) (2.0 g, 0.01 mol), bromoethyl acetate
(1.2 g, 0.004 mol), under the similar conditions was used for
1a and further crystallized from methanol to afford 1c.
Light brown; m.p. 87 C; yield: 85%. Anal. Calc. for
C17H16O5: C, 68.00; H, 5.33. Found: C, 67.96; H, 5.30%. IR
(KBr) mmax (cm
1): 2980, 2933 (methylene C–H), 1600, 1754
(C‚O), 1549(CHCH); 1H NMR (400 MHz, CDCl3): d/ppm:,
7.56 (1H, d{dd}, Jp,m,o = 0.8 Hz, 1.7 Hz, 7.8 Hz, Ar-H), 7.45
(1H, d, Jtrans = 15.2 Hz, H-2), 7.38 (1H, d, Jtrans = 15.3 Hz,
H-3), 7.24 (2H, dd, J= 3.3 Hz, Ar-H), 6.93 (1H, d, Ar-H),
7.07 (1H, m, Ar-H), 7.02(1H, m, Ar-H), 6.82 (1H, m, Ar-H),
4.24 (2H, q, Jvic = 6.9 Hz, –OCH2), 1.34(3H, t,
Jvic = 7.2 Hz, –CH3), 5.18(2H, s, –CH2);
13C NMR
(400 MHz, CDCl3): d/ppm: 191.2 (2C‚O), 155.8, 154.2,
143.6 (C‚C), 142.5, 132.5, 131.7, 130.3, 128.5, 126.6, 125.4,
120.2 114.6(Ar-C), 72.4 (OCH2), 68.5(CH2), 55.4(CH3); MS;
m/z (M+)301.
2.3.3. (2E)-1-[2-(Naphthalen-2-ylmethoxy)phenyl]-3-(furan-
2-yl)prop-2-en-1-one (1d)
A suspension of (1) (2.0 g, 0.01 mol), 1-chloromethyl-
napthalene (1.4 g, 0.004 mol), under the similar conditions
was used for 1a and further crystallized from methanol to
afford 1d.
Light brown; m.p. 94 C; yield: 88%. Anal. Calc. for
C24H18O3: C, 81.35; H, 5.08. Found: C, 81.31; H, 5.04%. IR
(KBr) mmax (cm
1): 1633 (C‚O), 1589(CH‚CH); 1H NMR
(400 MHz, CDCl3): d/ppm: 8.01 (1H, dd, J= 7.8 Hz, Ar-H),
7.80 (1H, d, Jo = 7.8 Hz, Ar-H), 7.91 (1H,d,
Jtrans = 15.7 Hz, H-3), 7.54 (1H, dd, J= 1.0, 1.7 Hz, Ar-H),
7.47 (1H, d, Jtrans = 15.7 Hz, H-2), 7.31 (2H, d, J= 3.4 Hz,
Ar-H), 7.24 (4H, m, Ar-H), 7.05 (2H, m, Ar-H), 7.09 (1H,
d{dd}, Jp,m,o = 0.9 Hz, 1.6 Hz, 7.8 Hz, Ar-H), 6.81 (2H, m,
Ar-H), 5.49 (2H, s, –CH2);
13C NMR (400 MHz, CDCl3): d/
ppm: 192.3 (C‚O), 154.7, 153.3, 142.6 (C‚C), 138.7
(C‚C), 142.6, 132.5, 131.4, 130.3, 129.4, 128.8, 128.8, 127.5,
126.6, 126.6, 125.3, 124.5, 122.6, 121.5, 120.4, 118.5, 114.3,
114.3 (Ar–C), 74.04(CH2); m/z (M
+) 355.
2.3.4. (5R)-5-(Furan-2-yl)-1-phenyl-3-[2-(prop-2-en-1-yloxy)
phenyl]-4,5-dihydro-1H-pyrazole (2a)
A mixture of -1-[2-(prop-2-en-1-yloxy)phenyl]-3-(thiophen-2-
yl) prop-2-en-1-one (1a) (0.5 g, 0.0015 mol) was reﬂuxed with
phenyl-hydrazine (0.800 ml, 0.004 mol) in dry EtOH (30 ml)
and catalytic amount of glacial acetic acid for at 80 C for
8 h. The progress of reaction was monitored by TLC. After
completion of the reaction, the solvent was removed under
reduced pressure and the residue obtained was puriﬁed bycolumn chromatography (20:80, diethyl ether–petroleum
ether) to obtain a solid that was crystallized from EtOH to
yield pyrazolines 2a.
Dark brown; m.p. 138 C; yield: 86%. Anal. Calc. for
C22H20O2 N2: C, 76.74, H, 5.81, N, 8.13. Found; C, 76.70;
H, 5.78; N, 8.09%. IR (KBr) mmax (cm
1): 3308 (N–H), 1585
(C‚N), 1483 (N–N); 1H NMR (400 MHz, CDCl3): d/ppm:
7.52 (5H, m, Ar-H), 7.02 (2H, m, Ar-H), 7.32 (1H, d{dd},
Jp,m,o = 0.7 Hz, 1.8 Hz, 7.5 Hz, Ar-H), 6.7 (1H, m, Ar-H),
6.8 (1H, d, Ar-H), 6.02 (2H, m, Ar-H), 5.32 (2H, t,
J= 6.7 Hz, -CH2), 4.52 (1H, dd, –CH), 4.64 (2H, dd,
Jvic = 6.1 Hz, –CH2); 5.25 (1Hx, dd, Jxa = 6.7 Hz,
Jxb = 11.6 Hz), 3.52 (1Ha, dd, Jax = 6.7 Hz, Jab = 16.7 Hz),
3.24 (1Hb, dd, Jbx = 11.6 Hz, Jba = 16.7 Hz);
13C NMR
(400 MHz, CDCl3): d/ppm: 156.7 (C‚N), 156.2, 155.2,
154.4, 144.2, 136.4, 131.5, 130.9, 129.8, 129.8, 128.2, 127.5,
125.5, 123.2, 123.2, 121.8, 116.7 (Ar-C), 77.3 (pyr. ring, C-5),
76.70 (CH2), 70.01 (CH2), 67.01 (pyr. ring, C-4), 46.1(CH);
MS; m/z (M+) 345.
2.3.5. (5R)-5-(Furan-2-yl)-1-phenyl-3-[2-(benzyloxy)phenyl]-
4,5-dihydro-1H-pyrazole (2b)
Pyrazoline 2b was obtained from the reaction of 1b (0.5 g,
0.0015 mol) with phenyl-hydrazine (0.430 g, 0.00398 mol)
under the similar conditions as used for 2a and further crystal-
lized from ethanol to afford 2b.
Blackish brown, m.p. 125 C; yield: 85%. Anal. Calc. for
C26H22O2N2: C, 79.18, H, 5.58; N, 7.10. Found: C, 79.15; H,
5.54; N, 7.06%. IR (KBr) mmax (cm
1): 3317 (N–H), 1596
(C‚N), 1493 (N–N); 1H NMR (400 MHz, CDCl3): d/ppm:
6.82 (1H, d, Jo = 7.8 Hz, Ar-H), 7.34 (1H, d{dd},
Jp,m,o = 0.9 Hz, 1.4 Hz, 7.8 Hz, Ar-H), 7.25 (3H, m, Ar-H),
7.21 (5H, m, Ar-H), 7.12 (5H, m, Ar-H), 7.04 (2H, m, Ar-
H), 5.32 (2H, s, –CH2), 5.23 (1Hx, dd, Jxa = 6.5 Hz,
Jxb = 11.2 Hz), 3.82 (1Ha, dd, Jax = 6.5 Hz, Jab = 17.1 Hz),
3.52 (1Hb, dd, Jbx = 11.2 Hz, Jba = 17.1 Hz);
13C NMR
(400 MHz, CDCl3): d/ppm: 156.1 (C‚N), 153.4, 152.3,
142.3, 142.2, 133.2, 130.1, 129.6, 129.6, 128.2, 128.2, 127.8,
127.2, 126.2, 126.2 125.2, 124.7, 124.7, 118.2, 116.2, 115.2,
114.6, 114.6 (Ar-C), 76.21 (pyr. ring, C-5), 67.23 (pyr. ring,
C-4), 64.02 (CH2); MS; m/z (M
+) 395.
2.3.6. (5R)-5-(Furan-2-yl)-1-phenyl-3-[2-(ethyloxy)phenyl]-
4,5-dihydro-1H-pyrazole (2c)
Pyrazoline 2b was obtained from the reaction of 1c (0.5 g,
0.0015 mol) with phenyl-hydrazine (0.430 g, 0.00398 mol)
under the similar conditions as used for 2a and further crystal-
lized from ethanol to afford 2c.
Radish brown; m.p. 127 C; yield: 92%. Anal. Calc. for
C23H22N2O4: C, 70.76; H, 5.64; N, 7.17. Found: C, 70.72; H,
5.61; N, 7.14%. IR (KBr) mmax (cm
1): 2878, 2889 (methylene
C–H), 3369 (N–H), 1755 (C‚O), 1587 (C‚N) 1457 (N–N);
1H NMR (400 MHz, CDCl3): d/ppm: 6.87 (1H, d, Ar-H),
7.06 (2H, m, Ar-H), 7.35 (1H, d{dd}, Jp,m,o = 0.8 Hz,
1.7 Hz, 7.8 Hz, Ar-H), 7.23 (3H, m, Ar-H), 7.81 (5H, m, Ar-
H), 5.25 (1Hx, dd, Jxa = 6.5 Hz, Jxb = 11.8 Hz), 4.61 (2H, s,
–CH2),4.01 (2H, q, Jvic = 6.4 Hz, –OCH2), 3.82 (1Ha, dd,
Jax = 6.5 Hz, Jab = 16.6 Hz), 3.42 (1Hb, dd, Jbx = 11.8 Hz,
Jba = 16.6 Hz), 1.25(3H, t, Jvic = 6.9 Hz,-CH3);
13C NMR
(400 MHz, CDCl3): d/ppm: 190.5 (C‚O), 156.6 (C‚N),
155.6, 155.2, 154.2, 144.4, 136.7, 131.2, 130.6, 129.4, 129.4,
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(pyr. ring, C-5), 72.2 (OCH2), 67.6 (CH2), 67.01 (pyr. ring,
C-4), 55.2 (CH3); MS; m/z (M
+) 391.
2.3.7. (5R)-5-(Furan-2-yl)-1-phenyl-3-[2-(naphthalen-2-
ylmethoxy prop-2-en-1-yloxy)phenyl]-4,5-dihydro-1H-pyrazole
(2d)
Pyrazoline 2d was obtained from the reaction of 1d (0.5 g,
0.0015 mol) with phenyl-hydrazine (0.430 g, 0.00398 mol)
under the similar conditions as used for 2a and further crystal-
lized from ethanol to afford 2d.
Radish brown; m.p. 158 C; yield: 94%, Anal. Calc. for
C30H24N2O2: C, 81.08; H, 5.40; N, 6.30. Found: C, 81.04; H,
5.37; N, 6.25%. IR (KBr) mmax (cm
1): 3314 (N–H), 1586
(C‚N), 1445 (N–N); 1H NMR (400 MHz, CDCl3): d/ppm:
8.02 (2H, m, Ar-H), 7.52 (1H, d{dd}, Jp,m,o = 0.8 Hz,
1.9 Hz, 7.6 Hz, Ar-H), 7.49 (5H, m, Ar-H), 7.10 (7H, m, Ar-
H), 6.82 (4H, m Ar-H), 5.23 (1Hx, dd, Jxa = 6.7 Hz,
Jxb = 11.8 Hz), 5.04 (2H, s, –CH2), 3.62 (1Ha, dd,
Jax = 6.7 Hz, Jab = 16.2 Hz), 3.23 (1Hb, dd, Jbx = 11.8 Hz,
Jba = 16.2 Hz);
13C NMR (400 MHz, CDCl3): d/ppm:
156.7(C‚N), 155.2, 154.3 142.6, 144.2, 135.2, 131.9, 130.7,
129.2, 129.2, 128.7, 128.7, 127.6, 126.5, 126.4, 126.4, 125.6,
124.3, 124.3, 123.8, 123.7, 122.6, 121.4, 121.4, 120.4, 118.2,
115.5 (Ar-C), 74.6 (pyr. ring, C-5), 71.2 (CH2), 68.3 (pyr. ring,
C-4); m/z (M+) 445.
3. Results and discussion
The present study describes, the synthesis and antibacterial
evaluation of some pyrazoline derivatives 2a–2d that were test-
ed for in vitro antibacterial activity using the disc-diffusion
method by measuring and the diameter of the zone of inhibi-
tion measured in mm. It was found that all the compounds
were screened in vitro for their antibacterial activity against
a variety of Gram-positive, Gram-negative bacterial strains,
such as A. hydrophila, Y. enterocolitica, L. monocytogenes
and S. aureus emerging pathogens responsible for gastroin-
testinal. Looking at the structure–activity relationship, com-
pounds 2a, 2b, 2c and 2d exhibit signiﬁcant activities while
2b and 2d exhibit good activity as compared to standard
known antibiotics, such as Gentamicin (10 mcg) and
Tetracycline (30 mcg) that were used for comparison purposes
and the antibacterial screening data are recorded in Tables 1
and 2. On the basis of the above observations, modiﬁcation
will be done to improve antibacterial activity.
Assignment of selected characteristic IR bands provides sig-
niﬁcant indications for the formation of the cyclized pyrazoline
analogues of the phenyl hydrazine 2a–2d. In starting material
alkoxy chalcones, 1a–1d (C‚O) and (CH‚CH), functional
absorbed in the expected region; (C‚O) at 1603–1754 cm1
and (CH‚CH) at 1552–1598 cm1, respectively. The IR spec-
tra of the compounds showed m(C‚N) stretching at 1585–
1596 cm1 and m(N–N) stretching vibration at 1445–
1493 cm1, respectively, which also conﬁrm the formation of
desired pyrazoline compounds.
The 1H NMR spectra (400 MHz, CDCl3), the signals corre-
sponding to the double hydrogens (H-2 and 3) at d 7.43–7.52,
and 7.38–7.91 alkoxy chalcones 1a–1d were found missing
altogether which indicates the involvement of the enone moiety
during the cyclization reactions and the coupling value ofJ= 15.2–15.7 Hz between theses hydrogens describes the trans
geometry around the C-2 and C-3 double bonds. The aromatic
protons were located at d 6.7–7.9, respectively. The downﬁeld
resonance of the H-3 as compared to H-2 could be ascribed to
the electron deﬁcient nature of the b-carbon in the enone moi-
ety. The major feature of this spectrum was the signals of the
pyrazoline 2a–2d ring proton (H-x) and (H-a and b) which
were found in the region at d 5.23–5.25 (1H, dd, Jxa = 6.5–
6.7 Hz, Jxb = 11.2–11.8 Hz) and 3.23–3.82 ppm (1H, dd,
Jax = 6.5–6.7 Hz, Jab = 16.1–17.1 Hz) describes the trans rela-
tionship between HX and Hb & Ha are geminally placed at C-
4,which clearly describes the inter-relationship between the H-
x, b and a. The proposed expression 2a–2d the strong deshield-
ing of the C5 (H-a and b) protons compared with the C4 (H-x)
protons of the pyrazoline ring can be assumed due to its struc-
ture Fig. 2. The protons belonging to the aromatic ring and the
other cyclic groups were observed with the expected chemical
shift and integral values.
Finally, 13C NMR (400 MHz, CDCl3) spectra of all com-
pounds were recorded in DMSO and spectral signals are in
good agreement with the probable structures. The carbon of
C‚O and C‚C displayed signals at 191.2–191 and 141.5–
144.6 ppm in 1a–1d. The methylene groups for 1c and 2c were
resonating at d 55.2–55.4 ppm (CH3) and d 72.2–72.4 ppm
(OCH2); the downﬁeld resonance of the former suggests their
placement near an electronegative oxygen atom. The signals
are due to the aromatic carbons and the carbon at 1-N substi-
tuted aliphatic group. The C4 and C5 carbon of pyrazoline res-
onated at 42.3–68.3 and 62.4–77.4 ppm, respectively. The
downﬁeld resonance of former as compared to C-4 could be
attributed to its benzylic nature and proximity to nitrogen
atom. The other resonates were showed at their usual position
in Section 2.
Characteristic peaks were observed in the mass spectra of
all compounds, which followed the similar fragmentation pat-
tern. The spectrum of the compound 2a showed a molecular
ion peak (M+) at m/z 345. The characteristic peaks observed
within the mass spectra of pyrazoline compounds are given
in experimental section.
It may be concluded that this study describes the general
method for the synthesis of some pyrazolines linked through
the 5-aryl ring under normal conditions. These results show
that compounds 2b and 2d are better antibacterial agents
against A. hydrophila, Y. enterocolitica, L. monocytogenes,
and S. aureus as compared to Gentamicin and Tetracycline.
Thus the accumulation of the pyrazoline derivatives will better
antibacterial agents for therapeutic use.
4. Conclusions
In the present studies, this research examined the antibacterial
activities of the pyrazoline derivatives from alkoxy chalcones
that were found to be more active among all pyrazoline com-
pounds while 2b and 2d displayed as good antibacterial agents
as compared to Gentamicin and Tetracycline. The molecular
structure of these active compounds showed property of pyra-
zoline; these compounds might be more efﬁcacious drugs
against these bacteria and their biological effects which could
be helpful in designing more potent antibacterial agents.
3 4
5N
N
Ha
O-CH 2-R
Hb
HX O
1
2
Figure 1 Schematic diagram indicating the ring conformation of
compounds 2a–2d.
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All the synthesized compounds of bis-pyrazoline derivatives
were evaluated for in vitro antibacterial activity by using disk
diffusion method and the Minimum Inhibitory Concentration
(MIC) as compared to antibiotics positive controls. The results
of antibacterial activity and Minimum Inhibitory
Concentration (MIC) are summarized in Tables 1 and 2
respectively.
5.1. Materials and method
Pure cultures A. hydrophila, Y. enterocolitica, L. monocytoge-
nes, and S. aureus were grown in brain heart infusion broth
for sensitivity testing. Mueller Hinton agar (Hi Media) and
pyrazoline compounds 2a–2d absolutely diluted (concentration
of 40, 30, 20 and 10 mcg) were applied as described by Bauer
et al. (1966). The strains were tested against the following
antibiotics (Hi Media): Gentamicin 10 mcg and Tetracycline
30 mcg. These were enriched in BHIB for 6–8 h at 37 C, the
cultures were streaked on differential media agar plates using
a cotton swab. With an antibiotic disc dispenser, the discs were
placed on the agar surface. After 30 min of pre-diffusion time,
the plates were incubated at 37 C for 18–24 h, after incuba-
tion, the diameter of the inhibition zones were measured and
compared to the interpretive chart of performance standards
for antimicrobial disk susceptibility tests (Hi Media) and clas-
siﬁed as resistant, intermediate or sensitive.
5.2. In vitro antibacterial activities
In vitro antibacterial activities of pyrazoline 2a–2d derivatives
were carried out using the culture of A. hydrophila, Y.Table 2 Minimum Inhibition Concentration (MIC) of pyrazol
Tetracycline) (Unit, mcg).
Compounds (MIC) (MIC) Corresponding eﬀect on micro
A. hydrophila Y. ente
2a 10 10
2b 30 30
2c 40 40
2d 20 20
Gentamicin 10 10
Tetracycline 30 30
Table 1 Antibacterial activity of pyrazoline derivatives, positive con
halo zone test (Unit, mm).
Compounds Corresponding eﬀect on microorganisms
A. hydrophila Y. enteroco
2a 15.6 16.4
2b 22.3 21.4
2c 14.6 14.5
2d 21.7 25.2
Oﬂoﬂoxine 25.1 13.3
Gentamicin 21.2 –
Tetracycline 13.4 20.3
DMSO – –enterocolitica, L. monocytogenes, and S. aureus by the disc-dif-
fusion method using nutrient broth medium [contained (mcg/
ml): beef extract 1 g; peptone 5 g; pH 7.0]. In the disc-diffusion
method, sterile paper discs (0.5 mm) impregnated with com-
pound dissolved in dimethylsulfoxide (DMSO) at a concentra-
tion of 100 mcg/mL were used. Gentamicin and Tetracycline
were used as the standard drugs, where as DMSO poured disk
was used as negative control. Then, the paper discs impregnat-
ed with the solution of the compounds were tested placed on
the surface of the media inoculated with the microorganism.
The plates were incubated at 18 h, at 37 C. After incubation,
the diameters of the inhibition zones were measured. The pyra-
zoline derivatives were further checked by MIC method and
results are presented in Tables 1 and 2. The in vitro studies
result showed that compounds 2b and 2e are of highest activityine derivatives and standard drugs (Ampicillin, Gentamicin,
ganisms (Unit, mcg)
rocolitica L. monocytogenes S. aureus
10 10
30 30
40 40
20 20
10 10
30 30
trol (oﬂoﬂoxine) and negative control (DMSO) measured by the
litica L. monocytogenes S. aureus
13.4 14.6
24.3 22.8
15.5 15.5
19.4 23.6
12.2 16.2
– 171
12.2 14.4
– –
OH
O
+
OH
O
CH3
NaOH
0 oC / EtOH
K2CO 3 / PTC /
PhNHNH 2 /
EtOH / 
O
O
CH2 R
O
2a -2d
1a -1d
glacial acitic acid
PTC=Bu 4N
+I-
where  R = -CH=CH 2,  -Ph,   -COOEt,
 dry acetone
1
Δ
3 4
5N
N
H a
O-CH 2-R
H b
H X O
OH
O
O
1
2
2
3
3
2
R-CH 2-X /
(1a,2a ) (1b, 2b) (1c, 2c) (1d, 2d)
Figure 2 Schematic diagram indicating the synthesis of compounds 2a–2d.
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aureus among all the pyrazolines when compared to antibi-
otics. The susceptibility of the bacteria to the test compounds
were determined by the formation of an inhibitory zone after
48 h of incubation at 37 C. The molecular structure of these
active compounds showed enhanced activity. The distinct dif-
ferences in the antibacterial property of these compounds fur-
ther justify the purpose of this study. The importance of such
work lies in the possibility that the new compounds might be
more efﬁcacious drugs against bacteria for which a thorough
investigation regarding the structure–activity relationship,
toxicity and their biological effects which could be helpful in
designing more potent antibacterial agents for therapeutic
use (Fig. 1).
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